Our healthcare products are carefully designed to boost your well-being and prevent health complications. For more details about our health products, please contact us today.

BPC-157

BENEFITS MAY INCLUDE

  • Supports cognitive performance
  • Supports joint health
  • Protects against drug-induced damage
  • Restores the serotonergic transport system
  • Protects the dopaminergic system
  • Enhances the GABAergic system
  • Reverses opioid tolerance
  • Accelerates wound healing
  • Ligament healing (knee, rotary)
  • Benefits for ulcers in the stomach
  • Benefits for intestinal damage
  • May help irritable bowel disease
  • Promotes lipolysis
  • Improves overall skin appearance
  • Repairs skin barrier proteins

BRIEF OVERVIEW

BPC-157, composed of 15 amino acids, is a partial sequence of body protection compounds (BPC) discovered in and isolated from human gastric juice. Experimentally, it has been demonstrated to accelerate the healing of different wounds, including tendons, muscles, nervous system, and superior healing of damaged ligaments. Those who suffer from discomfort due to muscle sprains, tears, and damages may benefit from treatment with this peptide. It can also help aid skin burns to heal at a faster rate and increase blood flow to damaged tissues.

CLINICAL REFERENCES

1. Cerovecki, Tomislav; Bojanic, Ivan; Brcic, Luka; Radic, Bozo; Vukoja, Ivan; Seiwerth, Sven; Sikiric, Predrag (September 2010). “Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat”. Journal of Orthopaedic Research. 28 (9): 1155– 1161. doi:10.1002/jor.21107.

2. ISSN 1554-527X. PMID 20225319. 2. “Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response”. PMID 17186181.

COMMON FORMULAS & PROTOCOLS

  • BPC-157 (10mg) Lyophilized Vial
  • 300mcg SQ injection nightly for 30 days
  • BPC-157 (500mcg) Capsule
  • One capsule daily for 30 days BPC-157 (500mcg) Sublingual Troche
  • One troche daily for 30 days BPC-157 (500mcg) Suppository
  • One suppository daily for 30 days BPC-157 (1mg/g) Anti-Inflammatory Cream
  • Apply 1/4g – 1g daily for 30 days BPC-157 (1mg/g) Organic Bio-Cream (facial)
  • Apply 1-2 pumps daily for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPYBREMELANOTIDE (PT-141)

BENEFITS MAY INCLUDE

  • HSDD (hypoactive sexual desire disorder) in premenopausal women
  • Beneficial for low libido (male & female)
  • Increase energy
  • Beneficial for ED (erectile dysfunction)
  • Helps enhance sexual satisfaction
  • Skin pigmentation (sunless tanning agent)

BRIEF OVERVIEW

PT-141 (Bremelanotide) is a synthetic peptide developed from Melanotan 2 (MT-II). PT-141 is used for the treatment of erectile dysfunction or impotence in men and HSDD (hypoactive sexual desire disorder) in women. PT-141 is a peptide that was originally developed as a sunless tanning agent. It is a melanocyte-stimulating hormone (MSH) that affects sexual arousal, aiding enhanced libido levels and penile erections. Unlike all PDES inhibitors, PT-141 does not target the vascular system. Instead, it acts on the nervous system via the activation of neurons in the hypothalamus to increase sexual desire.

CLINICAL REFERENCES

1. Shadiack AM, Sharma SD, Earle DC, Spana C, Hallam TJ. 2007;7(11):1137-44. Melanocortins in the treatment of male and female sexual dysfunction.

2. Rosen RC1, Diamond LE, Earle DC, Shadiack AM, Molinoff PB 2004 Apr;16(2):135-42. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra.

COMMON FORMULAS & PROTOCOLS

  • Bremelanotide (PT-141) 10,000mcg/ml w/ B6 50mg/ml
  • 2ml Vial
  • 0.1ml SQ injection 30 minutes to 6 hours prior to sexual activity for males
  • 0.2ml SQ injection 30 minutes to 6 hours prior to sexual activity for females
  • Bremelanotide (PT-141) w/B6
  • (5/25mg/ml) Nasal Spray 10ml Bottle
  • 2-4 sprays per nostril 30-60 minutes prior to sexual activity

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (CJC-1295)

BENEFITS MAY INCLUDE

  • Increased protein synthesis
  • Improves sleep quality
  • Increases bone density
  • Accelerates injury recovery
  • Improves immune system
  • Increases protein synthesis
  • Increases energy
  • Increases IGF-1
  • Increases in lean body mass

BRIEF OVERVIEW

CJC-1295 consists of 30 amino acid peptide hormones that have shown promising and amazing results as a Growth Hormone Releasing Hormone (GHRH) analog. Research supports that CJC-1295 stimulates HGH secretion and can provide a steady increase of HGH with minimal effect on cortisol and prolactin levels. This means increased protein synthesis, thus promoting growth and fat loss simultaneously.

CLINICAL REFERENCES

1. Teichman, Sam L.; Neale, Ann; Lawrence, Betty; Gagnon, Catherine; Castaigne, Jean-Paul; Frohman, Lawrence A. (2006). “Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults”. The Journal of Clinical Endocrinology & Metabolism. 91 (3): 799–805. doi:10.1210/jc.2005-1536. ISSN 0021-972X. PMID 16352683.

2. Ionescu, Madalina; Frohman, Lawrence A. (2006). “Pulsatile Secretion of Growth Hormone (GH) Persists during Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog”. The Journal of Clinical Endocrinology & Metabolism. 91 (12): 4792–4797. doi:10.1210/jc.2006-1702. ISSN 0021-972X.

COMMON FORMULAS & PROTOCOLS

  • CJC-1295 (10mg) Lyophilized Vial
  • 300mcg SQ injection nightly for 30 days CJC-1295 / Ipamorelin (4/4mg) Lyophilized Vial
  • 200/200mcg daily SQ injection 5 days on, 2 days off CJC-1295 / Ipamorelin (5/9mg) Lyophilized Vial
  • 250/450mcg daily SQ injection 5 days on, 2 days off CJC-1295 (500mcg) Sublingual Troche
  • One troche daily for 30 days CJC-1295 / Ipamorelin (300/300mcg) Sublingual Troche – One troche daily for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (DIHEXA)

BENEFITS MAY INCLUDE

  • Improves cognitive function
  • Helps in the treatment of Alzheimer’s Disease and Parkinson’s Disease
  • Improves long and short-term memory problems
  • Helps manage depression
  • Enhances creative thinking and social interaction
  • Improves heart health
  • Improves brain focus

BRIEF OVERVIEW

Dihexa also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth factor (HGF) and potentiates its activity at its receptor, c-Met. Dihexa as been found to potently improve cognitive function in animal models of Alzheimer’s disease-like mental impairment. In an assay of neurotrophic activity, Dihexa was found to be seven orders of magnitude more potent than brain-derived neurotrophic factor. An orally active, blood-brain barrier permeable compound was subsequently developed with the potential to treat Alzheimer’s disease and other disorders that would benefit from augmented synaptic connectivity.

CLINICAL REFERENCES

1. Joseph W. Harding; John W. Wright; Caroline C. Benoist; Leen H. Kawas; Gary A. Wayman (3 December 2013). “Patent US 8598118 – Hepatocyte growth factor mimics as therapeutic agents”. Retrieved 11 October 2015.

2. Alene T. McCoy; Caroline C. Benoist; John W. Wright; Leen H. Kawas; Jyote Bule-Ghogare; Mingyan Zhu; Suzanne M. Appleyard; Gary A. Wayman; Joseph W. Harding (January 2013). “Evaluation of metabolically stabilized angiotensin IV analogs as pro-cognitive/anti-dementia agents”. The Journal of Pharmacology and Experimental Therapeutics. 344 (1): 141–154. doi: 10.1124/jpet.112.199497. PMC 3533412. PMID 23055539.

COMMON FORMULAS & PROTOCOLS

  • Dihexa (1mg) Capsule
  • One capsule daily for 30 days Dihexa (2mg) Capsule
  • One capsule daily for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (GHK-Cu)

BENEFITS MAY INCLUDE

  • Repairs skin barrier proteins
  • Improves skin elasticity and firmness
  • Reduces hyper-pigmentation and skin spots
  • Stimulates skin collagen
  • Improves overall skin appearance
  • Reduces inflammation
  • Improves wound healing and reduce infections
  • Increases hair growth and follicle size

BRIEF OVERVIEW

GHK-Cu is a tripeptide with the amino acid sequence glycyl-histidyl-lysine. It naturally occurs in human plasma. It has also been found in saliva and urine. In plasma, the level of GHK declines as you age. This decline as the GHK-level coincides with a noticeable decrease in the regenerative capacity of an organism. GHK-Cu functions as a complex with copper that stimulates collagen production, accelerates wound healing and contraction, improves the take of transplanted skin, and also possesses anti-inflammatory properties.

CLINICAL REFERENCES

1. L. Pickart, J. H. Freedman, W. J. Loker, et al., “Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells,” Nature, vol. 288, no. 5792, pp. 715–717, 1980.

2. D. Downey, W. F. Larrabee Jr., V. Voci, and L. Pickart, “Acceleration of wound healing using glycyl-histidyl-lysine copper (II),” Surgical Forum, vol. 25, pp. 573–575, 1985. 3. H. Ehrlich, “Stimulation of skin healing in immunosuppressed rats,” in Proceedings of the Symposium on Collagen and Skin Repair, Reims, France, September 1991.

COMMON FORMULAS & PROTOCOLS

  • GHK-Cu (5mg/ml) Organic Bio-Cream (facial)
  • Apply 1-2 pumps daily for 30 days GHK-Cu (5mg/ml) Foam (scalp)
  • Apply 1ml to scalp nightly for 30 days GHK-Cu / BPC-157 (2mg/2mg/ml) Organic Bio-Cream (facial)
  • Apply 1-2 pumps daily for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPY IBUTAMOREN (MK-677)

BENEFITS MAY INCLUDE

  • Promotes lipolysis
  • Increases bone density
  • Increases in lean body mass
  • Increase muscle mass
  • Improves sleep quality
  • Increases energy
  • Increases endurance
  • Improves cellular repair
  • Increases IGF-1
  • Supports cognitive performance
  • Supports joint health

BRIEF OVERVIEW

Ibutamoren (MK-677) is a potent, long-acting, orally-active, selective, and non-peptide agonist of the ghrelin receptor and a growth hormone secretagogue, mimicking the growth hormone (GH)-stimulating action of the endogenous hormone ghrelin. It has been shown to increase the secretion of several hormones including GH and insulin-like growth factor 1 (IGF-1) and produces sustained increases in the plasma levels of these hormones without affecting cortisol levels.

CLINICAL REFERENCES

1. Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DB, Cheng K, Chan WW, Butler B, Hickey G (July 1995). “Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue”. Proceedings of the National Academy of Sciences of the United States of America. 92 (15): 7001–5. doi:10.1073/pnas.92.15.7001. PMC 41459.

2. Chapman IM, Pescovitz OH, Murphy G, Treep T, Cerchio KA, Krupa D, Gertz B, Polvino WJ, Skiles EH, Pezzoli SS, Thorner MO (October 1997). “Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulinlike growth factor-I axis in selected GH-deficient adults”. The Journal of Clinical Endocrinology and Metabolism. 82 (10): 3455– 63. doi:10.1210/jc.82.10.3455. PMID 9329386.

COMMON FORMULAS & PROTOCOLS

  • Ibutamoren (MK-677) 12.5mg Capsule
  • One capsule daily on an empty stomach for 30 days Ibutamoren (MK-677) 25mg Capsule
  • One capsule daily on an empty stomach for 30 days Ibutamoren (MK-677) 25mg Troche
  • One troche daily on an empty stomach for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (IPAMORELIN)

BENEFITS MAY INCLUDE

  • Promotes lipolysis
  • Increased collagen production
  • Increase in lean body mass
  • Improves sleep quality
  • Increased energy
  • Increased endurance
  • Improved cellular repair
  • Increased IGF-1
  • Counteracts glucocorticoid catabolic effects
  • Less appetite stimulation
  • Less release of cortisol, prolactin, and aldosterone

BRIEF OVERVIEW

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) and ghrelin mimetic with growth hormone (GH) releasing activity. Ipamorelin mimics ghrelin and binds to the ghrelin receptor (or GH secretagogue receptor, GHSR) in the brain, thereby selectively stimulating the release of GH from the pituitary gland. This results in increased plasma GH levels, which would affect many biological processes. Besides its presence in the brain, GHSR can also be found in the gastrointestinal tract, heart, lung, liver, kidney, pancreas, adipose tissue, and immune cells. Unlike other GH releasing peptides Ipamorelin only stimulates GH release in a manner very similar to that of Hormone Releasing Hormone.

CLINICAL REFERENCES

1. Gobburu, Jogarao V. S.; Agersø, Henrik; Jusko, William J.; Ynddal, Lars (1999).Pharmacokinetic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers”. Pharmaceutical Research. 16 (9): 1412–1416. doi:10.1023/A: 1018955126402. ISSN 0724-8741.

2. Raun, K; Hansen, B.; Johansen, N.; Thogersen, H; Madsen, K; Ankersen, M; Andersen, P. (1998). “Ipamorelin, the first selective growth hormone secretagogue”. European Journal of Endocrinology. 139 (5): 552–561. doi:10.1530/eje.0.1390552. ISSN 0804-4643.

COMMON FORMULAS & PROTOCOLS

  • Ipamorelin (9mg) Lyophilized Vial
  • 300mcg SQ injection daily for 30 days Ipamorelin (300mcg) Sublingual Troche
  • One troche daily for 30 days CJC-1295 / Ipamorelin (4/4mg) Lyophilized Vial
  • 200/200mcg daily SQ injection 5 days on, 2 days off CJC-1295 / Ipamorelin (5/9mg) Lyophilized Vial
  • 250/450mcg daily SQ 5 injection days on, 2 days off

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (SERMORELIN ACETATE)

BENEFITS MAY INCLUDE

  • Increase in lean body mass
  • Promotes lipolysis
  • Increases energy
  • Increases strength
  • Accelerates wound healing
  • Improves cardiovascular and immune function
  • Improves sleep quality
  • Improves bone density
  • Improves skin quality and higher collagen density
  • Increases IGF-1

BRIEF OVERVIEW

Sermorelin (brand names Geref) is a peptide analog of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion to diagnose growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.

CLINICAL REFERENCES

1. Prakash A, Goa KL (August 1999). “Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency”. BioDrugs. 12 (2): 139–57. doi:10.2165/00063030-199912020-00007. PMID 18031173.

2. Pharmacology (Rang, Dale, Ritter & Moore, ISBN 0-443-07145-4, 5th ed., Churchill Livingstone 2003).

COMMON FORMULAS & PROTOCOLS

  • Sermorelin (9mg) Freeze-Dried Vial
  • 300mcg SQ injection nightly for 30 days Sermorelin (15mg) Freeze-Dried Vial
  • 500mcg SQ injection nightly for 30 days Sermorelin (300mcg) Sublingual Troche
  • One troche daily for 30 days Sermorelin (500mcg) Sublingual Troche
  • One troche daily for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (TESOFENSINE)

BENEFITS MAY INCLUDE

  • Promotes lipolysis
  • Increases energy
  • Increases in lean body mass
  • Stimulates metabolism
  • Suppresses appetite
  • Improves sleep quality
  • Decreases hemoglobin A1C and insulin levels
  • Decreases triglycerides and cholesterol

BRIEF OVERVIEW

Tesofensine is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs. Originally, Tesofensine was developed by a biotechnology company for the treatment of Alzheimer’s and Parkinson’s disease but was subsequently dropped from development for these applications after early trial results showed limited efficacy for the treatment of these diseases. However, weight loss was consistently reported as an adverse event in the original studies, especially in overweight or obese patients, thus changing the course of clinical trials towards the treatment of obesity. Tesofensine primarily acts as an appetite suppressant but additionally can act by increasing resting energy expenditure.

CLINICAL REFERENCES

1. Jo-Anne Gilbert , Christoph Gasteyger , Anne Raben, Dieter H. Meier, Arne Astrup, Anders Sjödin. “The Effect of Tesofensine on Appetite Sensations”. https://doi.org/10.1038/oby.2011.197

2. Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM (2008). “Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomized, double-blind, placebo-controlled trial”. Lancet. 372 (9653): 1906–13. doi:10.1016/S0140-6736(08)61525-1. PMID 18950853.

COMMON FORMULAS & PROTOCOLS

  • Tesofensine (500mcg) Capsule
  • One capsule daily for 30 days

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (THYMOSIN ALPHA-1)

BENEFITS MAY INCLUDE

  • Modulates immune function and inflammation
  • Improves chronic fatigue
  • Suppresses tumor growth
  • Improves autoimmune function
  • Anti-fungal and anti-bacterial properties
  • Protects against oxidative damage
  • Treats Lyme Disease
  • Increases vaccine effectiveness
  • Helps eliminate unhealthy cells and stop infection or cancer growth

BRIEF OVERVIEW

Thymosin Alpha-1 has been known as an excellent immune modulator. Thymosin is a small protein produced naturally by the thymus gland which stimulates the development of disease-fighting T-cells. The thymus is an integral part of your immune system, where individual T-cells are made to respond to the millions of bacteria, fungi, or viruses that could invade your body. Commonly prescribed for the treatment for chronic viral diseases, Thymosin Alpha-1 has also been shown to increase innate immunity factors and help fight against harmful autoimmune processes. It helps control inflammation associated with chronic diseases, which can cause excess fatigue.

CLINICAL REFERENCES

1. You J, Zhuang L, Cheng HY, Yan SM, Yu L, Huang JH, Tang BZ, Huang ML, Ma YL, Chongsuvivatwong V, et al. World J Gastroenterol. Efficacy of thymosin alpha-1 and interferon-alpha in the treatment of chronic viral hepatitis B: 2006 Nov 7; 12(41): 6715-21.

2. Sherman KE, Sjogren M, Creager RL, Damiano MA, Freeman S, Lewey S, Davis D, Root S, Weber FL, Ishak KG, et al. Hepatology. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. 1998 Apr; 27(4):1128-35.

COMMON FORMULAS & PROTOCOLS

  • Thymosin Alpha-1 (15mg) Vial
  • 450mcg SQ injection daily for 30 days Thymosin Alpha-1 (2000mcg/ml) Nasal Spray 15ml Bottle
  • 200mcg (1-2 sprays) each nostril daily

*Additional references available. Contact us for more info.

PEPTIDE THERAPY (ZINC THYMULIN)

BENEFITS MAY INCLUDE

  • Improves hair growth
  • Prevents hair loss
  • Improves endogenous hair pigmentation
  • Treats androgenic alopecia
  • Useful for both male and female
  • Can be combined with alternate hair growth protocols

BRIEF OVERVIEW

Zinc Thymulin (also known as “thymic factor”) is a nonapeptide produced by two distinct epithelial populations in the thymus first described by Bach in 1977. Its biological activity and antigenicity depend upon the presence of the metal zinc in the molecule. This pharmacologically active metallopeptide induces the differentiation of T-cells and enhances several functions of the various T-cell subsets in normal or partially thymus-deficient recipients. Zinc Thymulin has been used for the treatment of hair loss. A recent study indicated that topical treatment with zinc thymulin increased hair growth over 6 months; furthermore, there were no systemic or local side effects from the treatment. The zinc thymulin metallo-peptide optionally also improves endogenous hair pigmentation by stimulating melanogenesis in grey hair.

CLINICAL REFERENCES

1. Meier N, Langan D, Hilbig H, Bodo E, Farjo NP, et al. (2012) Thymic peptides differentially modulate human hair follicle growth. J Invest Dermatol 132: 1516-1519.

2. Renner D, Schuster D, Heim ME (1986) Experiences using the ‘‘thymu-skin’’ hair cure for the prevention of alopecia in cytostatic treatment. Onkologie 5: 285-286

COMMON FORMULAS & PROTOCOLS

  • Zinc Thymulin Topical 50mcg/ml Foam (scalp) 30ml Bottle
  • Apply 1ml to scalp nightly before bed

*Additional references available. Contact us for more info.

PEPTIDE THERAPY FORMULAS & DOSING

Peptide Lyophilized Injectable Formulas

Description Size/Strength 30-Day Dose
BPC-157 10 mg vial 300 mcg
Bremelanotide (PT-141) w/B6 10mg/ml (2ml vial) 0.1 – 0.2ml before sexual activity
CJC-1295 10 mg vial 300 mcg
CJC-1295/Ipamorelin 4/4 mg vial 200/200 mcg
CJC-1295/Ipamorelin 5/9 mg vial 250/450 mcg
Ipamorelin 9 mg vial 300 mcg
Sermorelin 9 mg vial 300 mcg
Thymosin Alpha-1 3mg/ml (5ml vial) 450 mcg

Peptide Oral Troche Formulas (Other Strengths Available)

Description Size/Strength
BPC-157 500 mcg
1000mcg
CJC-1295/Ipamorelin 300/300 mcg
Ipamorelin 300 mcg
500 mcg
Sermorelin Acetate 300 mcg
500 mcg
Sermorelin/Ipamorelin 300/300mcg

Other Peptide Formulas

Description Size/Strength
BPC-157 Capsule 500 mcg
1000mcg
BPC-157 Anti-Inflammatory Cream 1mg/ml (30g)
BPC-157 Organic Bio-Cream (facial) 1mg/ml (30g)
BPC-157 Suppository 500 mcg
1000mcg
Bremelanotide (PT-141) w/B6 Nasal Spray 5mg/25mg/ml (10ml bottle)
Dihexa Capsule 1mg
2mg
10mg
GHK-Cu Organic Bio-Cream 5mg/ml (15ml bottle)
GHK-Cu Topical Foam 5mg/ml (30ml bottle)
GHK-Cu w/ BPC-157 Organic Bio-Cream 2mg/2mg/ml (15ml bottle)
Ibutamoren (MK-677) Capsule 12.5 mg
25 mg
Tesofensine Capsule 500mcg
Thymosin Alpha-1 Nasal Spray 2000mcg/ml (15ml bottle)
Zinc Thymulin Topical Foam 50mcg/ml (30ml bottle)

*Multiple strengths/blends for any non-sterile formulas can be compounded as prescribed.

Regensmart.com also offers the following peptide products:

  • AOD-9604
  • BPC-157
  • Bremelanotide (PT-141) w/B6
  • CJC-1295
  • CJC-1295 / Ipamorelin
  • Dihexa
  • GHK-Cu
  • GHK-Cu w/ BPC-157
  • Ibutamoren (MK-677)
  • Ipamorelin
  • Kisspeptin-10
  • Sermorelin
  • Thymosin Alpha-1
  • Thymosin Beta-4
  • Zinc Thymulin

IMMUNE BOOSTING FORMULAS & PROTOCOLS:

THYMOSIN ALPHA-1

  • (15mg) Vial
    • 450mcg SQ injection daily for 30 days
  • (2000mcg/ml) Nasal Spray 15ml Bottle
    • 200mcg (1-2 sprays) each nostril daily

THYMOSIN BETA-4

  • (15mg) Vial
    • 450mcg SQ injection daily for 30 days
  • (2000mcg/ml) Nasal Spray 15ml Bottle
    • 200mcg (1-2 sprays) each nostril daily